SurvivorNet on MSN
Enhertu significantly cuts recurrence rates for women with high-risk HER2-positive breast cancer — the practice-changing DESTINY-Breast05 trial
DESTINY-Breast05 is a large phase 3 trial in women with HER2-positive early-stage breast cancer who had chemotherapy and ...
Our Lady of Lourdes' high-risk breast cancer clinic to aid in breast cancer detection and prevention
LAFAYETTE PARISH — A breast cancer clinic in Lafayette is giving women in Acadiana easier access to specialized screenings, genetic risk assessments and early detection tools, the perfect highlight to ...
A new study asked whether women with an elevated risk of breast cancer were adhering to recommended MRI screening after genetic testing and counseling. Women with a BRCA mutation or other high-risk ...
The National Institute for Health and Care Excellence (NICE) has recommended ribociclib (Kisqali, Novartis) as an adjuvant treatment for early breast cancer in patients at high risk of recurrence. The ...
Interval cancers, diagnosed between screenings, often present more aggressively and are linked to breast density and hormone replacement therapy. A study found 30% of breast cancer cases in Swedish ...
WEST COLUMBIA, S.C. — Lexington Medical Center has launched a high-risk breast clinic to provide specialized support for women facing an elevated chance of developing breast cancer. While the average ...
When it comes to breast cancer, doctors say early detection is key, especially if you are high risk. Those at high risk include people who have a family history of cancer, increased breast density, ...
Using advanced medical algorithms, researchers have identified six breast texture patterns that may indicate a high risk for breast cancer. In a new study, one of the largest of its kind, published in ...
Previously reported results from monarchE showed that adjuvant abemaciclib plus endocrine therapy is associated with a significant improvement in invasive disease-free survival (IDFS) over endocrine ...
Please provide your email address to receive an email when new articles are posted on . The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among ...
Eric H. Yang, MD, emphasizes the need for collaboration and interventions to protect patients’ hearts during breast cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback